Short communicationDetermination of Etoposide phosphate (cas 117091-64-2) intermediates by gradient liquid chromatography using postcolumn derivatization with cuprammonium hydroxide
-
Add time:09/03/2019 Source:sciencedirect.com
Allyl 4,6-O-ethylidene-β-d-glucopyranoside is an intermediate used in the synthesis of Etoposide phosphate (cas 117091-64-2), a water-soluble derivative of the antineoplastic drug etoposide. In this paper, a method for the determination of allyl 4,6-O-ethylidene-β-d-glucopyranoside and related glucopyranosides is described. Samples are analyzed by gradient high-performance liquid chromatography using postcolumn derivatization with cuprammonium hydroxide. The method is used to monitor the ethylidenation reaction of allyl β-d-glucopyranoside with acetal to form allyl 4,6-O-ethylidene-β-d-glucopyranoside. Samples are chromatographed on an octadecyl-bonded phase column with aqueous acetonitrile. Triethylamine is added to the mobile phase to accelerate mutarotation and suppress anomeric separations. The column effluent is mixed via a postcolumn tee with cuprammonium hydroxide and monitored with ultraviolet detection at 310 nm.
We also recommend Trading Suppliers and Manufacturers of Etoposide phosphate (cas 117091-64-2). Pls Click Website Link as below: cas 117091-64-2 suppliers
Prev:Micronization of etoposide using solution-enhanced dispersion by supercritical CO2
Next:Influence of substituents in the phenyl ring on photophysical properties of 3-[2-(phenyl)benzoxazol-5-yl]alanine derivatives) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Micronization of etoposide using solution-enhanced dispersion by supercritical CO209/02/2019
- RESEARCHPhysical and Chemical Stability of Etoposide phosphate (cas 117091-64-2) Solutions09/01/2019
- Short communicationPhase I and pharmacokinetic study of a water-soluble etoposide prodrug, Etoposide phosphate (cas 117091-64-2) (BMY-40481)08/31/2019
- In vitro and in vivo evaluation of etoposide - silk wafers for neuroblastoma treatment08/30/2019
- Etoposide phosphate (cas 117091-64-2) or etoposide with cisplatin in the treatment of small cell lung cancer: Randomized Phase II trial08/29/2019
- Optimization by design of etoposide loaded solid lipid nanoparticles for ocular delivery: Characterization, pharmacokinetic and deposition study08/28/2019
- In-vitro dissolution and microbial inhibition studies on anticancer drug etoposide with β-cyclodextrin08/27/2019
- Research ArticlePharmaceutics, Drug Delivery and Pharmaceutical TechnologyTransdermal Delivery of Etoposide phosphate (cas 117091-64-2) II: In Vitro In Vivo Correlations (IVIVC)08/26/2019
- Research ArticlePharmaceutics, Drug Delivery and Pharmaceutical TechnologyTransdermal Delivery of Etoposide phosphate (cas 117091-64-2) I: In Vitro and In Vivo Evaluation08/25/2019


